Traditional bisulfite sequencing damages DNA, while enzyme-based alternatives are inconsistent. A novel methylation analysis ...
Alongside Leah Blankenship and Lila Kaye, two neurodivergent graduate students from UO, Smear created the NeuroDiversity Innovation Centers for Excellence in Neuroscience, otherwise known as “NICE in ...
Phase III trial for KLU156 (ganaplacide/lumefantrine, or GanLum), meets primary endpoint of non-inferiority to standard of care Coartem® (artemether-lumefantrine) Demonstrates PCR-corrected cure rate ...
A tailored approach with rapid needs assessment before and during implementation to address local testing site barriers in ...